Bristol-Myers, AstraZeneca Agree To End Drug Patent Fight
A Delaware federal judge on Monday dismissed Bristol-Myers Squibb Co.'s litigation accusing AstraZeneca of infringing cancer treatment patents to create a rival immunotherapy drug, after the pharmaceutical giants reached an agreement....To view the full article, register now.
Already a subscriber? Click here to view full article